Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Intelligent Medical Devices, Inc. (IMDx) Introduces a CE-Marked Automated Assay for the Detection of C. difficile Including Hypervirulent Strains

August 1, 2011 By Bio-Medicine.Org

CAMBRIDGE, Mass., Aug. 1, 2011 /PRNewswire/ — Intelligent
Medical Devices, Inc. (IMDx) today announced it has received
CE-Mark for a high-throughput automated assay for the detection of
C. difficile, including the A-B+ 1470 variant, as
well as the NAP1 strain. The IMDx™ C. difficile assay
for the Abbott m2000™ is the first assay released
under a multi-year distribution agreement between Abbott and IMDx
whereby IMDx will design, develop, regulatory clear, and
manufacture assays for the Abbott FDA cleared m2000
instrument.

Designed utilizing IMDx’s proprietary bioinformatics process,
the IMDx C. difficile assay for the Abbott m2000
demonstrates a sensitivity of 95.7 percent and a specificity of 100
percent (internal comparison data).  C. difficile may
develop after prolonged antibiotic use and is the most frequent
cause of health-care-associated diarrhea, also causing more severe
intestinal conditions such as colitis. The bacterium is easily
transmitted via direct contact with high-touch surfaces in patient
rooms, contaminated patient-care items, and hands of health-care
workers.

“Our assays are developed to incorporate evolving clinical
needs. Not only do we offer automated detection of toxigenic C.
difficile
genes, shortening the time needed to diagnose
infections, but we also cover the detection of hypervirulent
strains, including NAP1, and tcdB-variant strains, including
1470.  Early identification of pathogens is critical in
improving patient healthcare, shortening hospital stays, and
reducing expenses,” says Alice Jacobs, MD, Chairman & CEO of
IMDx.

About IMDx

Based in Cambridge, MA, IMDx (www.IntelligentMDx.com)
is an innovative company that designs, develops and manufactures
molecular diagnostic products. IMDx has developed molecular
solutions that are clinically impactful and competitiv

‘/>”/>

SOURCE

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech